1
|
Kalsbeek AMF, Chan EKF, Corcoran NM,
Hovens CM and Hayes VM: Mitochondrial genome variation and prostate
cancer: a review of the mutational landscape and application to
clinical management. Oncotarget. 8:71342–71357. 2017. View Article : Google Scholar : PubMed/NCBI
|
2
|
Lee SU and Cho KH: Multimodal therapy for
locally advanced prostate cancer: The roles of radiotherapy,
androgen deprivation therapy, and their combination. Radiat Oncol
J. 35:189–197. 2017. View Article : Google Scholar : PubMed/NCBI
|
3
|
Puche-Sanz I, Alvarez-Cubero MJ,
Pascual-Geler M, Rodriguez-Martinez A, Delgado-Rodriguez M,
Garcia-Puche JL, Expósito J, Robles-Fernández I, Entrala-Bernal C,
Lorente JA, et al: A comprehensive study of circulating tumour
cells at the moment of prostate cancer diagnosis: Biological and
clinical implications of EGFR, AR and SNPs. Oncotarget.
8:70472–70480. 2017. View Article : Google Scholar : PubMed/NCBI
|
4
|
Terracciano D, Terreri S, de Nigris F,
Costa V, Calin GA and Cimmino A: The role of a new class of long
noncoding RNAs transcribed from ultraconserved regions in cancer.
Biochim Biophys Acta. 1868:449–455. 2017.
|
5
|
Sun Y, Zou X, He J and Mao Y:
Identification of long non-coding RNAs biomarkers associated with
progression of endometrial carcinoma and patient outcomes.
Oncotarget. 8:52604–52613. 2017.PubMed/NCBI
|
6
|
Su W, Xu M, Chen X, Chen N, Gong J, Nie L,
Li L, Li X, Zhang M and Zhou Q: Long noncoding RNA ZEB1-AS1
epigenetically regulates the expressions of ZEB1 and downstream
molecules in prostate cancer. Mol Cancer. 16:1422017. View Article : Google Scholar : PubMed/NCBI
|
7
|
Jia J, Li F, Tang XS, Xu S, Gao Y, Shi Q,
Guo W, Wang X, He D and Guo P: Long noncoding RNA DANCR promotes
invasion of prostate cancer through epigenetically silencing
expression of TIMP2/3. Oncotarget. 7:37868–37881. 2016. View Article : Google Scholar : PubMed/NCBI
|
8
|
Misawa A, Takayama K, Urano T and Inoue S:
Androgen-induced long noncoding RNA (lncRNA) SOCS2-AS1 promotes
cell growth and inhibits apoptosis in prostate cancer cells. J Biol
Chem. 291:17861–17880. 2016. View Article : Google Scholar : PubMed/NCBI
|
9
|
Wu H, Wu R, Chen M, Li D, Dai J, Zhang Y,
Gao K, Yu J, Hu G, Guo Y, et al: Comprehensive analysis of
differentially expressed profiles of lncRNAs and construction of
miR-133b mediated ceRNA network in colorectal cancer. Oncotarget.
8:21095–21105. 2017.PubMed/NCBI
|
10
|
Zhou M, Diao Z, Yue X, Chen Y, Zhao H,
Cheng L and Sun J: Construction and analysis of dysregulated
lncRNA-associated ceRNA network identified novel lncRNA biomarkers
for early diagnosis of human pancreatic cancer. Oncotarget.
7:56383–56394. 2016.PubMed/NCBI
|
11
|
Makishima H, Ishikawa H, Tanaka K, Mori Y,
Mizumoto M, Ohnishi K, Aihara T, Fukumitsu N, Okumura T and Sakurai
H: A retrospective study of late adverse events in proton beam
therapy for prostate cancer. Mol Clin Oncol. 7:547–552. 2017.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Ready D, Yagiz K, Amin P, Yildiz Y, Funari
V, Bozdag S and Cinar B: Mapping the STK4/Hippo signaling network
in prostate cancer cell. PLoS One. 12:e01845902017. View Article : Google Scholar : PubMed/NCBI
|
13
|
Wu Y, Liang S, Xu B, Zhang R, Zhu M, Zhou
W, Zhang S, Guo J, Xu L and Zhu H: Long noncoding RNA eosinophil
granule ontogeny transcript inhibits cell proliferation and
migration and promotes cell apoptosis in human glioma. Exp Ther
Med. 14:3817–3823. 2017. View Article : Google Scholar : PubMed/NCBI
|
14
|
Aiello A, Bacci L, Re A, Ripoli C,
Pierconti F, Pinto F, Masetti R, Grassi C, Gaetano C, Bassi PF, et
al: MALAT1 and HOTAIR long non-coding RNAs play opposite role in
estrogen-mediated transcriptional regulation in prostate cancer
cells. Sci Rep. 6:384142016. View Article : Google Scholar : PubMed/NCBI
|
15
|
Ahadi A, Brennan S, Kennedy PJ, Hutvagner
G and Tran N: Long non-coding RNAs harboring miRNA seed regions are
enriched in prostate cancer exosomes. Sci Rep. 6:249332016.
View Article : Google Scholar : PubMed/NCBI
|
16
|
Mehra R, Udager AM, Ahearn TU, Cao X, Feng
FY, Loda M, Petimar JS, Kantoff P, Mucci LA and Chinnaiyan AM:
Overexpression of the long non-coding RNA SChLAP1 independently
predicts lethal prostate cancer. Eur Urol. 70:549–552. 2016.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Cao S, Wang Y, Li J, Lv M, Niu H and Tian
Y: Tumor-suppressive function of long noncoding RNA MALAT1 in
glioma cells by suppressing miR-155 expression and activating FBXW7
function. Am J Cancer Res. 6:2561–2574. 2016.PubMed/NCBI
|
18
|
Jiao F, Hu H, Yuan C and Wang L, Jiang W,
Jin Z, Guo Z and Wang L: Elevated expression level of long
noncoding RNA MALAT-1 facilitates cell growth, migration and
invasion in pancreatic cancer. Oncol Rep. 32:2485–2492. 2014.
View Article : Google Scholar : PubMed/NCBI
|
19
|
Ren S, Liu Y, Xu W, Sun Y, Lu J, Wang F,
Wei M, Shen J, Hou J, Gao X, et al: Long noncoding RNA MALAT-1 is a
new potential therapeutic target for castration resistant prostate
cancer. J Urol. 190:2278–2287. 2013. View Article : Google Scholar : PubMed/NCBI
|
20
|
Tano K, Mizuno R, Okada T, Rakwal R,
Shibato J, Masuo Y, Ijiri K and Akimitsu N: MALAT-1 enhances cell
motility of lung adenocarcinoma cells by influencing the expression
of motility-related genes. FEBS Lett. 584:4575–4580. 2010.
View Article : Google Scholar : PubMed/NCBI
|
21
|
Sebastian A, Hum NR, Hudson BD and Loots
GG: Cancer-osteoblast interaction reduces sost expression in
osteoblasts and up-regulates lncRNA MALAT1 in prostate cancer.
Microarrays (Basel). 4:503–519. 2015. View Article : Google Scholar : PubMed/NCBI
|
22
|
Chen X, Liu S, Zhao X, Ma X, Gao G, Yu L,
Yan D, Dong H and Sun W: Long noncoding RNA ILF3-AS1 promotes cell
proliferation, migration, and invasion via negatively regulating
miR-200b/a/429 in melanoma. Biosci Rep. 37(pii): BSR201710312017.
View Article : Google Scholar : PubMed/NCBI
|
23
|
Chaudhry MA: Expression pattern of small
nucleolar RNA host genes and long non-coding RNA in X-rays-treated
lymphoblastoid cells. Int J Mol Sci. 14:9099–9110. 2013. View Article : Google Scholar : PubMed/NCBI
|